Market Cap 819.46M
Revenue (ttm) 403.14M
Net Income (ttm) -22.68M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -5.63%
Debt to Equity Ratio -0.50
Volume 59,090,402
Avg Vol 17,213,020
Day's Range N/A - N/A
Shares Out 257.69M
Stochastic %K 75%
Beta 1.07
Analysts Hold
Price Target $2.97

Company Profile

Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia cardiovascular disease who...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 734 887 3903
Address:
3891 Ranchero Drive, Suite 150, Ann Arbor, United States
RobbieMontana
RobbieMontana Jul. 15 at 3:50 PM
$ESPR ✌️
0 · Reply
Enjoyycall
Enjoyycall Jul. 15 at 3:30 PM
$ESPR fraud. Trading on inside info will jail you
0 · Reply
Spaceequiped
Spaceequiped Jul. 15 at 3:10 PM
$ESPR Funny, post your real numbers. Your fuel is almoat that
1 · Reply
Endlessall
Endlessall Jul. 15 at 3:04 PM
$CPIX Management is so important. I was in $ESPR and by luck made a little money but the opportunity cost was big and not having management "aligned" with shareholders really sucked.
2 · Reply
MikeLikesCheddar
MikeLikesCheddar Jul. 15 at 2:31 PM
$ESPR got ESPR’d now getting PYPL’d, at least I’ll have a healthy profit on both! Same scenario though.
0 · Reply
Enjoyycall
Enjoyycall Jul. 15 at 1:52 PM
$ESPR I hate it when I take a screenshot and my battery is lower than 50%. Well, I can atleast pay bills this month. Transfers are so troublesome.
2 · Reply
Enjoyycall
Enjoyycall Jul. 15 at 1:14 PM
$ESPR imagine posting and have such little figures when you post. You have Omar type money lol
0 · Reply
OldManLogan
OldManLogan Jul. 15 at 11:51 AM
$ESPR I know it's not the ending that was hoped for or expected here (by literally an order of magnitude), hopefully Sheldon and even Ben never work again after this... ideally they should be doing time for their role in this. If anyone is looking for me, you're likely to find me on the NGEN (regrowing neurons to treat basically every CNS condition) ICU (massively improve outcomes for Sepsis patients) or the lonely LNZA board (company's just going to solve all the world's energy problems, lol) This is my new holy trinity of 20+ baggers... All the best to the great community we had here.
0 · Reply
samruwell
samruwell Jul. 15 at 11:21 AM
$ESPR anyone know when 212 are paying out on this pls ?
3 · Reply
Gary9912
Gary9912 Jul. 15 at 1:14 AM
$IBRX $ESPR Good luck to all of my friends over at ESPR , we made money but not what we had hoped for, I’ll be more selective going forward with biotechs but I’m increasing my position in IBRX, ImmunityBio, Dr Patrick’s immunotherapy has shown much promise on many types of cancer. Great video below with two compelling testimonials (40 min mark) from actual cancer patients, Aline and Jim who were written off by Drs when all modern treatments had failed. And then there is Lori Mills a huge advocate for Anktiva when her husband was given 12 months to live with brain cancer and it’s been 9 months since then and he’s had 4 clean brain scans since being treated with Antktiva. X post below the YouTube video Take a look , it’s approved in US for bladder cancer and the FDA is looking at expanding the label. It’s approved in SA for lung cancer. https://youtu.be/L6gbF1kuHiQ?is=iEf4YAf4GU-NYCr3 https://x.com/lorimills4ca42/status/2059811871684006255?s=46&t=0qGPcTfX8as0XYMijymapw
3 · Reply
Latest News on ESPR
Esperion Therapeutics Transcript: EGM 2026

Jul 8, 2026, 8:00 AM EDT - 7 days ago

Esperion Therapeutics Transcript: EGM 2026


Esperion Therapeutics Proxy statement: Proxy filing

Jun 16, 2026, 8:00 AM EDT - 4 weeks ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Proxy statement: Proxy filing

Jun 8, 2026, 8:00 AM EDT - 5 weeks ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Proxy statement: Proxy filing

May 29, 2026, 8:00 AM EDT - 6 weeks ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Transcript: AGM 2026

May 28, 2026, 8:00 AM EDT - 6 weeks ago

Esperion Therapeutics Transcript: AGM 2026


Esperion Therapeutics Quarterly report: Q1 2026

May 8, 2026, 7:00 AM EDT - 2 months ago

Esperion Therapeutics Quarterly report: Q1 2026


Esperion downgraded to Hold from Buy at Needham

2026-05-04T19:10:14.000Z - 2 months ago

Esperion downgraded to Hold from Buy at Needham


Esperion Therapeutics Proxy statement: Proxy filing

May 4, 2026, 8:00 AM EDT - 2 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion downgraded to Hold from Buy at Jefferies

2026-05-01T19:26:03.000Z - 2 months ago

Esperion downgraded to Hold from Buy at Jefferies


Esperion downgraded to Neutral from Overweight at Piper Sandler

2026-05-01T18:06:50.000Z - 2 months ago

Esperion downgraded to Neutral from Overweight at Piper Sandler


Esperion downgraded to Neutral from Buy at H.C. Wainwright

2026-05-01T15:12:52.000Z - 2 months ago

Esperion downgraded to Neutral from Buy at H.C. Wainwright


Esperion Therapeutics Proxy statement: Proxy filing

May 1, 2026, 8:00 AM EDT - 2 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Proxy statement: Proxy filing

May 1, 2026, 8:00 AM EDT - 2 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion to be Acquired by ARCHIMED

May 1, 2026, 7:00 AM EDT - 2 months ago

Esperion to be Acquired by ARCHIMED


Esperion to Report First Quarter 2026 Financial Results on May 7

Apr 23, 2026, 8:00 AM EDT - 2 months ago

Esperion to Report First Quarter 2026 Financial Results on May 7


Esperion Therapeutics Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 3 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 3 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion showcases new data from CLEAR Outcomes trial

2026-03-30T13:21:46.000Z - 3 months ago

Esperion showcases new data from CLEAR Outcomes trial


Esperion price target raised to $5 from $4 at Citizens

2026-03-13T09:36:20.000Z - 4 months ago

Esperion price target raised to $5 from $4 at Citizens


Esperion Therapeutics Earnings Call Transcript: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 4 months ago

Esperion Therapeutics Earnings Call Transcript: Q4 2025


Esperion Therapeutics Annual report: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 4 months ago

Esperion Therapeutics Annual report: Q4 2025


Esperion Therapeutics Earnings release: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 4 months ago

Esperion Therapeutics Earnings release: Q4 2025


Esperion Therapeutics Slides: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 4 months ago

Esperion Therapeutics Slides: Q4 2025


Esperion reports Q4 EPS 22c, consensus 28c

2026-03-10T10:06:52.000Z - 4 months ago

Esperion reports Q4 EPS 22c, consensus 28c


Esperion Therapeutics Slides: Corporate presentation

Mar 9, 2026, 7:00 AM EDT - 4 months ago

Esperion Therapeutics Slides: Corporate presentation


Esperion Therapeutics Transcript: M&A announcement

Mar 3, 2026, 8:00 AM EST - 4 months ago

Esperion Therapeutics Transcript: M&A announcement


Esperion Therapeutics Press release: M&A announcement

Mar 3, 2026, 8:00 AM EST - 4 months ago

Esperion Therapeutics Press release: M&A announcement


Esperion Therapeutics Slides: M&A announcement

Mar 3, 2026, 8:00 AM EST - 4 months ago

Esperion Therapeutics Slides: M&A announcement


Esperion signs definitive acquisition of Corstasis Therapeutics

2026-03-03T11:05:38.000Z - 4 months ago

Esperion signs definitive acquisition of Corstasis Therapeutics


Esperion reaches settlement agreement with Alkem

2026-02-17T13:16:28.000Z - 5 months ago

Esperion reaches settlement agreement with Alkem


Esperion Therapeutics Transcript: KOL Event

Nov 11, 2025, 2:00 PM EST - 8 months ago

Esperion Therapeutics Transcript: KOL Event


Esperion Therapeutics Slides: KOL Event

Nov 11, 2025, 2:00 PM EST - 8 months ago

Esperion Therapeutics Slides: KOL Event


Esperion Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 8 months ago

Esperion Therapeutics Earnings Call Transcript: Q3 2025


Esperion Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 8 months ago

Esperion Therapeutics Quarterly report: Q3 2025


Esperion Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 8:00 AM EST - 8 months ago

Esperion Therapeutics Earnings release: Q3 2025


Esperion Therapeutics Slides: Q3 2025

Nov 6, 2025, 8:00 AM EST - 8 months ago

Esperion Therapeutics Slides: Q3 2025


Esperion Announces Pricing of Public Offering of Common Stock

Oct 7, 2025, 9:29 PM EDT - 10 months ago

Esperion Announces Pricing of Public Offering of Common Stock


Esperion Announces Proposed Public Offering of Common Stock

Oct 7, 2025, 4:01 PM EDT - 10 months ago

Esperion Announces Proposed Public Offering of Common Stock


Esperion Therapeutics Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Earnings Call Transcript: Q2 2025


Esperion Therapeutics Quarterly report: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Quarterly report: Q2 2025


Esperion Therapeutics Earnings release: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Earnings release: Q2 2025


Esperion Therapeutics Slides: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Slides: Q2 2025


Esperion Appoints Craig Thompson to Board of Directors

Jul 1, 2025, 8:06 AM EDT - 1 year ago

Esperion Appoints Craig Thompson to Board of Directors


Esperion Therapeutics Earnings Call Transcript: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Earnings Call Transcript: Q1 2025


Esperion Therapeutics Quarterly report: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Quarterly report: Q1 2025


Esperion Therapeutics Earnings release: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Earnings release: Q1 2025


Esperion Therapeutics Slides: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Slides: Q1 2025


Esperion Therapeutics Transcript: Status Update

Apr 24, 2025, 9:00 AM EDT - 1 year ago

Esperion Therapeutics Transcript: Status Update


Esperion Therapeutics Press release: Status Update

Apr 24, 2025, 9:00 AM EDT - 1 year ago

Esperion Therapeutics Press release: Status Update


Esperion Therapeutics Slides: Status Update

Apr 24, 2025, 9:00 AM EDT - 1 year ago

Esperion Therapeutics Slides: Status Update


Esperion Therapeutics Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Proxy statement: Proxy Filing


Esperion Therapeutics Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Proxy statement: Proxy Filing


Esperion Appoints Robert E. Hoffman to Board of Directors

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Esperion Appoints Robert E. Hoffman to Board of Directors


Esperion Therapeutics Earnings Call Transcript: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

Esperion Therapeutics Earnings Call Transcript: Q4 2024


Esperion Therapeutics Annual report: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

Esperion Therapeutics Annual report: Q4 2024


Esperion Therapeutics Earnings release: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

Esperion Therapeutics Earnings release: Q4 2024


Esperion Therapeutics Slides: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

Esperion Therapeutics Slides: Q4 2024


Esperion Therapeutics Transcript: KOL Event

Jan 22, 2025, 12:30 PM EST - 1 year ago

Esperion Therapeutics Transcript: KOL Event


Esperion Therapeutics Slides: KOL Event

Jan 22, 2025, 12:30 PM EST - 1 year ago

Esperion Therapeutics Slides: KOL Event


Esperion Therapeutics Slides: FY 2025

Jan 15, 2025, 6:45 PM EST - 1 year ago

Esperion Therapeutics Slides: FY 2025


Esperion Announces $210 Million Convertible Debt Financing

Dec 13, 2024, 6:00 AM EST - 1 year ago

Esperion Announces $210 Million Convertible Debt Financing


Esperion Therapeutics Earnings Call Transcript: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Esperion Therapeutics Earnings Call Transcript: Q3 2024


Esperion Therapeutics Quarterly report: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Esperion Therapeutics Quarterly report: Q3 2024


Esperion Therapeutics Earnings release: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Esperion Therapeutics Earnings release: Q3 2024


Esperion Therapeutics Slides: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Esperion Therapeutics Slides: Q3 2024


Esperion Therapeutics Earnings Call Transcript: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Esperion Therapeutics Earnings Call Transcript: Q2 2024


Esperion Therapeutics Quarterly report: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Esperion Therapeutics Quarterly report: Q2 2024


Esperion Therapeutics Earnings release: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Esperion Therapeutics Earnings release: Q2 2024


Esperion Therapeutics Slides: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Esperion Therapeutics Slides: Q2 2024


Esperion Therapeutics Slides: Corporate Presentation

Aug 8, 2024, 7:00 AM EDT - 2 years ago

Esperion Therapeutics Slides: Corporate Presentation


RobbieMontana
RobbieMontana Jul. 15 at 3:50 PM
$ESPR ✌️
0 · Reply
Enjoyycall
Enjoyycall Jul. 15 at 3:30 PM
$ESPR fraud. Trading on inside info will jail you
0 · Reply
Spaceequiped
Spaceequiped Jul. 15 at 3:10 PM
$ESPR Funny, post your real numbers. Your fuel is almoat that
1 · Reply
Endlessall
Endlessall Jul. 15 at 3:04 PM
$CPIX Management is so important. I was in $ESPR and by luck made a little money but the opportunity cost was big and not having management "aligned" with shareholders really sucked.
2 · Reply
MikeLikesCheddar
MikeLikesCheddar Jul. 15 at 2:31 PM
$ESPR got ESPR’d now getting PYPL’d, at least I’ll have a healthy profit on both! Same scenario though.
0 · Reply
Enjoyycall
Enjoyycall Jul. 15 at 1:52 PM
$ESPR I hate it when I take a screenshot and my battery is lower than 50%. Well, I can atleast pay bills this month. Transfers are so troublesome.
2 · Reply
Enjoyycall
Enjoyycall Jul. 15 at 1:14 PM
$ESPR imagine posting and have such little figures when you post. You have Omar type money lol
0 · Reply
OldManLogan
OldManLogan Jul. 15 at 11:51 AM
$ESPR I know it's not the ending that was hoped for or expected here (by literally an order of magnitude), hopefully Sheldon and even Ben never work again after this... ideally they should be doing time for their role in this. If anyone is looking for me, you're likely to find me on the NGEN (regrowing neurons to treat basically every CNS condition) ICU (massively improve outcomes for Sepsis patients) or the lonely LNZA board (company's just going to solve all the world's energy problems, lol) This is my new holy trinity of 20+ baggers... All the best to the great community we had here.
0 · Reply
samruwell
samruwell Jul. 15 at 11:21 AM
$ESPR anyone know when 212 are paying out on this pls ?
3 · Reply
Gary9912
Gary9912 Jul. 15 at 1:14 AM
$IBRX $ESPR Good luck to all of my friends over at ESPR , we made money but not what we had hoped for, I’ll be more selective going forward with biotechs but I’m increasing my position in IBRX, ImmunityBio, Dr Patrick’s immunotherapy has shown much promise on many types of cancer. Great video below with two compelling testimonials (40 min mark) from actual cancer patients, Aline and Jim who were written off by Drs when all modern treatments had failed. And then there is Lori Mills a huge advocate for Anktiva when her husband was given 12 months to live with brain cancer and it’s been 9 months since then and he’s had 4 clean brain scans since being treated with Antktiva. X post below the YouTube video Take a look , it’s approved in US for bladder cancer and the FDA is looking at expanding the label. It’s approved in SA for lung cancer. https://youtu.be/L6gbF1kuHiQ?is=iEf4YAf4GU-NYCr3 https://x.com/lorimills4ca42/status/2059811871684006255?s=46&t=0qGPcTfX8as0XYMijymapw
3 · Reply
Rustyton
Rustyton Jul. 14 at 11:30 PM
$ESPR lol, mine doubled too and it’s the min amount I was expecting. Sad it isn’t true
0 · Reply
profitsforall
profitsforall Jul. 14 at 10:31 PM
$ESPR Schwab - same - My account value for ESPR just doubled...IF only it were TRUE (CVR valued at $3.18)
0 · Reply
Dave_100
Dave_100 Jul. 14 at 9:03 PM
$ESPR at least Schwab now shows the CVR, but they are giving it a value of $3.18 per share by mistake. Logged in for a second and though wtf.
2 · Reply
Gary9912
Gary9912 Jul. 14 at 7:46 PM
$ESPR DJ sighting…🤣
0 · Reply
josh23941
josh23941 Jul. 14 at 6:37 PM
0 · Reply
maxhappy
maxhappy Jul. 14 at 4:54 PM
$ESPR One last message for Sheldung Koenig, the worst biotech CEO I have come across in many years:
1 · Reply
biotech_sellout
biotech_sellout Jul. 14 at 1:50 PM
0 · Reply
sofiastocks
sofiastocks Jul. 14 at 1:45 PM
$ESPR In the 1 share of east west my cvr??
1 · Reply
Rustyton
Rustyton Jul. 14 at 1:43 PM
$ESPR CVR shows in 401k account but not Schwab… anyone with Schwab seeing it?
1 · Reply
Enjoyycall
Enjoyycall Jul. 14 at 10:36 AM
$ESPR Anyone want to attack and say derogatory terms to the CEO…he did a great job.
2 · Reply
FyCkD_FuNnY
FyCkD_FuNnY Jul. 14 at 9:54 AM
$ESPR Money dropped on eTrade, waiting for CVR now...
2 · Reply
darioras
darioras Jul. 14 at 8:19 AM
$ESPR Looks like this board is going to disappear soon. Thanks for everyone who tried to help the community, I was really confident to a much different and greater end and that's why I dedicated big money and a lot of time to this, but sadly it didn't end up the way we hoped. Let's change to another chapter 🫡
2 · Reply